Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

DMBMPP

From Wikipedia, the free encyclopedia
(Redirected fromJuncosamine)
Chemical compound
Pharmaceutical compound
DMBMPP
Clinical data
Other namesJuncosamine
ATC code
  • None
Identifiers
  • 2-(2,5-dimethoxy-4-bromobenzyl)-6-(2-methoxyphenyl)piperidine
CAS Number
PubChemCID
ChemSpider
UNII
Chemical and physical data
FormulaC21H26BrNO3
Molar mass420.347 g·mol−1
3D model (JSmol)
  • COC(C=C(Br)C(OC)=C1)=C1C[C@@H]2CCC[C@@H](C3=C(OC)C=CC=C3)N2
  • InChI=1S/C21H26BrNO3/c1-24-19-10-5-4-8-16(19)18-9-6-7-15(23-18)11-14-12-21(26-3)17(22)13-20(14)25-2/h4-5,8,10,12-13,15,18,23H,6-7,9,11H2,1-3H3/t15-,18-/m0/s1
  • Key:KMVGLBONODPTDY-YJBOKZPZSA-N

DMBMPP, or2-(2,5-dimethoxy-4-bromobenzyl)-6-(2-methoxyphenyl)piperidine, is a2-benzylpiperidineanalog of thehallucinogenicN-benzylphenethylamine25B-NBOMe and was discovered in 2011 by Jose Juncosa in the group ofDavid E. Nichols atPurdue University.[1][2] DMBMPP differs from 25B-NBOMe by incorporating the amine within apiperidine ring, making for a more rigid molecular structure than that of the open-chain 25B-NBOMe. The presence of the piperidine ring introduces two stereocenters, thus, fourstereoisomers of this compound can be made.

Pharmacology

[edit]

The (S,S)-isomer ((2S,6S)-DMBMPP) is the most selectiveagonist for the human5-HT2A receptor yet discovered, with aKi of 2.5 nM at the human 5-HT2A receptor and with 124-fold selectivity for 5-HT2A over the structurally similar5-HT2C-receptor.[2] Together with25CN-NBOH,[3] (2S,6S)-DMBMPP is the only known 5-HT2A agonist to exhibit this level of selectivity.

LigandKi ± SEM (nM)Ki ± SEM (nM)Ki ± SEM (nM)
[3H] ketanserin[3H] mesulerginefold selectivity
h5-HT2Ah5-HT2Ch5-HT2C/h5-HT2A
2C-B6.0 ± 0.323.8 ± 2.69.5
25B-NBOMe0.19 ± 0.014.0 ± 0.421
(±)-DMBMPP5.3 ± 0.3520 ± 2298
(S,S)-(−)-DMBMPP2.5 ± 0.1310 ± 42124
(R,R)-(+)-DMBMPP2,100 ± 17128,600 ± 470027

See also

[edit]

References

[edit]
  1. ^Juncosa JI (2011-05-07).Organic synthesis combined with molecular modeling: A powerful approach to map the functional topography of dopamine and serotonin receptors (Ph.D. thesis). Purdue University.
  2. ^abJuncosa JI, Hansen M, Bonner LA, Cueva JP, Maglathlin R, McCorvy JD, Marona-Lewicka D, Lill MA, Nichols DE (January 2013)."Extensive rigid analogue design maps the binding conformation of potent N-benzylphenethylamine 5-HT2A serotonin receptor agonist ligands".ACS Chemical Neuroscience.4 (1):96–109.doi:10.1021/cn3000668.PMC 3547484.PMID 23336049.
  3. ^Hansen M, Phonekeo K, Paine JS, Leth-Petersen S, Begtrup M, Bräuner-Osborne H, Kristensen JL (March 2014)."Synthesis and structure-activity relationships ofN-benzyl phenethylamines as 5-HT2A/2C agonists".ACS Chemical Neuroscience.5 (3):243–9.doi:10.1021/cn400216u.PMC 3963123.PMID 24397362.
Psychedelics
(5-HT2A
agonists)
Benzofurans
Lyserg‐
amides
Phenethyl‐
amines
2C-x
25x-NBx
25x-NB
25x-NB3OMe
25x-NB4OMe
25x-NBF
25x-NBMD
25x-NBOH
25x-NBOMe
Atypical structures
25x-NMx
N-(2C)-fentanyl
3C-x
4C-x
DOx
HOT-x
MDxx
Mescaline (subst.)
TMAs
Others
Piperazines
Tryptamines
alpha-alkyltryptamines
x-DALT
x-DET
x-DiPT
x-DMT
x-DPT
Ibogaine-related
x-MET
x-MiPT
Others
Others
Dissociatives
(NMDAR
antagonists)
Arylcyclo‐
hexylamines
Ketamine-related
PCP-related
Others
Adamantanes
Diarylethylamines
Morphinans
Others
Deliriants
(mAChR
antagonists)
Others
Cannabinoids
(CB1 agonists)
Natural
Synthetic
AM-x
CPx
HU-x
JWH-x
Misc. designer cannabinoids
D2agonists
GABAA
enhancers
Inhalants
(MixedMOA)
κORagonists
Oneirogens
Others
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Retrieved from "https://en.wikipedia.org/w/index.php?title=DMBMPP&oldid=1270039958"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp